| Date | Title | Description |
| 09.03.2026 | Healthcare AI pilots outpace sector's regulatory readiness | - |
| 08.01.2026 | PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows | PathAI, a global leader in AI-powered pathology, announced a strategic collaboration with University Hospital Zurich (USZ) to deploy AISight Dx
, PathAI’s CE-IVD digital pathology platform, together with AIM-TumorCellularity (AIM-TC)
to sup... |
| 19.12.2025 | The rise and impact of AI in Biotechnology and Healthcare | - |
| 01.10.2025 | Avalara Launches Agentic Tax and Compliance™: AI Agents That Work for You | With unmatched tax expertise and technology innovation, Avalara is redefining compliance with a fleet of intelligent agents that initiate and execute tasks
DURHAM, N.C., Oct. 1, 2025 /PRNewswire/ -- Avalara, Inc. today unveiled Agentic Tax ... |
| 11.08.2025 | Vertical AI: The Rise of Industry-Specific Intelligence Rather than the traditional view of India as a consumer of global AI solutions, there is a growing opportunity today to take the lead in creatin... | Artificial Intelligence is advancing at a very rapid pace, and among the most exciting frontiers is the arrival of Vertical AI industry ~ vertical intelligence for areas like healthcare, law, agriculture, manufacturing, and finance. As comp... |
| 02.06.2025 | PathAI and Northwestern Medicine to Transform Pathology Diagnostics with AI | What You Should Know:
– PathAI, a provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system announced a strategic multi-year collaboration aimed at transforming pathology diag... |
| 18.04.2025 | Assort Health: $26 Million Secured For Specialty-Specific GenAI Platform For Managing Patient Phone Calls | Assort Health, which is a specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital... |
| 07.02.2025 | Revolutionizing Pathology: The Rise of AI in Cancer Detection | In the world of medicine, time is often the difference between life and death. The advent of artificial intelligence (AI) in pathology is a game-changer. It’s like having a supercharged assistant, tirelessly sifting through data to uncover ... |
| 06.02.2025 | Paige Expands PanCancer Detect to Identify Cancer in Over 40 Tissue Types | What You Should Know:
– Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.
– Originally launched in 2024 with the ability to iden... |
| 04.02.2025 | PathAI Launches PathAssist Derm, an AI-Powered Tool for Skin Lesion Analysis | What You Should Know:
– PathAI, a provider of AI-powered pathology solutions, today announced the launch of PathAssist Derm, an innovative tool designed to streamline the analysis of skin lesions.
– Available now on the AISight® Image Manag... |
| 25.01.2025 | Navigating the AI Frontier: Galileo's Agentic Evaluations Set to Transform AI Reliability | In the rapidly evolving landscape of artificial intelligence, trust is the new currency. As AI agents become integral to business operations, ensuring their reliability is paramount. Enter Galileo, a San Francisco-based startup that has jus... |
| 24.01.2025 | Qdrant's GPU-Accelerated Vector Indexing: A Game Changer for AI Applications | In the fast-paced world of artificial intelligence, speed is everything. Enter Qdrant, a trailblazer in the realm of open-source vector databases. On January 23, 2025, Qdrant unveiled a groundbreaking feature: platform-independent GPU-accel... |
| 24.01.2025 | The AI Arms Race: Navigating the Landscape of Fraud and Responsibility | In the digital age, the battle against fraud has taken on a new form. The rise of artificial intelligence (AI) has transformed the landscape, creating both opportunities and threats. As businesses rush to adopt AI technologies, they must al... |
| 24.01.2025 | The Future of Health and Security: Innovations from Noom and ZeroTrusted.ai | In a world where health and security are paramount, two companies are stepping up to redefine how we approach personal well-being and data protection. Noom and ZeroTrusted.ai are not just players in their respective fields; they are pioneer... |
| 24.01.2025 | Navigating the New Landscape of Governance, Risk, and Compliance in 2025 | In the world of business, Governance, Risk, and Compliance (GRC) is no longer a mere checkbox. It’s the backbone of operational excellence. As we step into 2025, organizations are shifting gears. They are no longer viewing GRC as a burden b... |
| 24.01.2025 | The Rise of AI in Data Management: Transforming Efficiency and Cost Control | In the fast-paced world of data management, innovation is the lifeblood of progress. Two recent announcements from Dataiku and DataBahn highlight a significant shift in how organizations approach data engineering and analytics. These develo... |
| 24.01.2025 | The New Wave of Data Empowerment: Plotly and Savant Lead the Charge | In the fast-paced world of data analytics, two companies are emerging as titans: Plotly and Savant Labs. Both have unveiled groundbreaking updates to their platforms, aiming to redefine how data professionals interact with their tools. Thes... |
| 23.01.2025 | MediaTek Adopts AI-Driven Cadence Virtuoso Studio and Spectre Simulation on NVIDIA Accelerated Computing Platform for 2nm Designs | Latest Virtuoso Studio release and Spectre Simulator deliver a 30% productivity gain for MediaTek’s 2nm design flow compared to prior Virtuoso releases Highlights:
Virtuoso Studio advanced optimization enhances MediaTek’s efficiency by 30% ... |
| 23.01.2025 | Launch of Progress Data Cloud Creates Platform to Accelerate AI Strategies and Digital Transformation | New offering empowers enterprises to simplify data operations and enhance AI capabilities in the cloud
Progress , the trusted provider of AI-powered digital experiences and infrastructure software, today announced the launch of Progress Dat... |
| 23.01.2025 | PathAI Partners with Discovery Life Sciences to Deploy First AI-Powered Biospecimen Solutions | Collaboration Marks First At-Scale Deployment of AI Technologies into Leading Commercial Biobank
PathAI, a leading provider of AI-powered technology for pathology, today announced a strategic partnership with Discovery Life Sciences, a lead... |
| 23.01.2025 | PathAI Partners to Deploy First AI-Powered Biospecimen Solutions | What You Should Know:
– PathAI, a leading provider of AI-powered technology for pathology, today announced a strategic partnership with Discovery Life Sciences, a leading biospecimens and specialty lab testing company, to offer Discovery’s ... |
| 23.01.2025 | Savant Unveils Breakthrough Innovation in New Release of AI Analytics Automation Platform | Data Analysts Celebrate Industry Firsts, Enhanced Features, and Hyper-Efficient Workflows
Savant Labs, the AI-powered automation platform for data analysts, today announced the latest release of its Analytics Automation platform. This relea... |
| 23.01.2025 | HCLTech and MIT Technology Review Insights Report Emphasizes Urgency for Enterprises to Implement Responsible AI Principles | Study reveals while 87% believe responsible AI practices are critical to adopt, 85% of all business executives polled are not well prepared to adopt them
A study by HCLTech, a leading global technology company, and MIT Technology Review Ins... |
| 23.01.2025 | Collibra Strengthens AI Governance Leadership with ISO 42001 Certification, AI Pact Commitment and the Delivery of the EU AI Act Assessment Tool | Collibra, the Data Intelligence company, announces three major milestones reinforcing its commitment to driving reliable and compliant AI governance. Collibra has achieved its ISO 42001 certification for AI Governance, signed on to the Euro... |
| 23.01.2025 | OP360 Unveils Game-Changing AI and Human Collaboration for Elevated Customer Experiences | OP360, a global leader in CX solutions, is setting new benchmarks by combining the power of AI with the human touch to redefine customer engagement.
OP360, a global leader in customer experience (CX) solutions, is setting new benchmarks by ... |
| 23.01.2025 | Hyperproof’s 6th Annual IT Risk and Compliance Benchmark Report Reveals an Increased Focus on GRC Maturity | Hyperproof, a trusted platform for operationalizing compliance and risk management, has released its 6th annual IT Risk and Compliance Benchmark Report today. Based on insights from 1,000 IT and GRC professionals, the in-depth report contai... |
| 23.01.2025 | Qdrant Launches the First Platform-Independent GPU-Accelerated Vector Indexing for Real-Time AI Applications | Qdrant, the leading high-performance open-source vector database, today introduced its platform-independent GPU-accelerated vector indexing. This new feature delivers up to 10x faster index-building times while leveraging cost-effective GPU... |
| 23.01.2025 | Survey Reveals Over 50 Percent of AI Leaders Plan to Augment Hyperscaler AI Investments | Over 200 AI leaders cite interoperability, governance, and scalability as key challenges limiting AI impact
Related Posts
Ati Motors Raises $20 Million Series B for Global Expansion of its AI-Powered Robotics Workforce
Jan 23, 2025
Basetwo ... |
| 23.01.2025 | ZeroTrusted.ai Unveils RAG and Agent Developer Upgrades, Redefining AI Security, Privacy, and Reliability | ZeroTrusted.ai launches advanced RAG and Agent Developer features, enhancing AI security, privacy, and reliability for sensitive and regulated environments.
ZeroTrusted.ai, the leading innovator in secure AI and machine learning solutions, ... |
| 23.01.2025 | Galileo Launches Agentic Evaluations to Empower Developers to Build Reliable AI Agents | The comprehensive solution gives developers the tools and insights needed to optimize agent performance and ensure readiness for real-world deployment
Galileo, the leading AI Evaluation Platform, today unveiled Agentic Evaluations, a transf... |
| 22.01.2025 | Cognite Appoints Alysa Taylor to Board of Directors | Microsoft CMO for Commercial Cloud and AI is focused on AI-driven Innovation
Related Posts
Ati Motors Raises $20 Million Series B for Global Expansion of its AI-Powered Robotics Workforce
Jan 23, 2025
Basetwo Raises $11.5M Series A to Trans... |
| 22.01.2025 | Workers Embrace Agentic AI Despite Concerns About Trust and Reliability, Says Research | Study reveals key areas organizations should focus on to ensure successful agentic AI adoption
Pegasystems Inc. The Enterprise Transformation Company™, today announced its new research exploring workers’ feelings toward agentic AI. While a ... |
| 22.01.2025 | Lumina AI Launches PrismRCL 2.6.0 with Advanced LLM Training Parameter | Lumina AI, a leader in CPU-optimized machine learning solutions, announces the release of PrismRCL 2.6.0, the latest upgrade to its flagship software designed to push the boundaries of performance and efficiency in machine learning. This re... |
| 22.01.2025 | DataBahn Announces Launch of Agentic AI “Cruz” to Optimize and Simplify Data Engineering and Management | Databahn.ai, a leader in Data Pipeline Management (DPM) and Data Fabric solutions, today announced Cruz, an AI agent purpose-built for all data engineering and operations tasks.
Leveraging the power of generative AI and large language model... |
| 22.01.2025 | Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer | New Body Age Prediction and Existing Body Composition Analysis Now Available to Everyone, Including Free Members of Noom
Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live bett... |
| 22.01.2025 | Persona Unveils Significant Advances in Detection of AI-based Face Spoofs | Enhancements bolster defenses against recent 50x surge in deepfakes
Persona, a leading global identity platform, today announced significant advancements in its AI-based face spoof detection capabilities. These updates strengthen Persona’s ... |
| 22.01.2025 | Dataiku Launches Dataiku Optimizer for Snowflake to Help Customers Monitor Consumption and Identify New Integrations | Eligible joint customers can now use Snowflake Capacity commitments to purchase Dataiku software subscriptions via Snowflake Marketplace
Dataiku, the Universal AI Platform, today announced the launch of Dataiku Optimizer for Snowflake, a Sn... |
| 22.01.2025 | Postman Launches AI Agent Builder: A Comprehensive Suite of Solutions for Creating Functional Agents | AI Agent Builder offers one-stop solution combining LLMs, APIs, and visual workflows to streamline agent development
Related Posts
Ati Motors Raises $20 Million Series B for Global Expansion of its AI-Powered Robotics Workforce
Jan 23, 2025... |
| 22.01.2025 | Plotly Announces Dash Enterprise 5.6: Build Data Apps Smarter with Plotly AI | Plotly has announced Dash Enterprise (DE) 5.6, a major update designed to empower data and AI teams to build data apps smarter with Plotly AI. By integrating advanced AI capabilities and enhancing scalability, this release empowers business... |
| 22.01.2025 | Nebius AI Studio Introduces One of the Most Cost-Effective Suite for Text-to-image Generation With Leading Open-Source AI Models | With the latest addition of Flux Schnell, Flux Dev, and SDXL models, Nebius AI Studio becomes one of the most competitive providers of text-to-image AI models in the market
Nebius AI Studio’s standard capacity of 100M+ tokens per minute for... |
| 04.01.2025 | The AI Revolution in Healthcare: A Double-Edged Sword | The future of healthcare is a battleground. On one side, artificial intelligence (AI) promises miracles. On the other, it raises ethical dilemmas and risks. As we step into 2025, the stakes are high. The question looms: will AI be our savio... |
| 03.01.2025 | Your Health - Which Way Will AI Go in 2025? | If 2023 was the year that generative AI came crashing into the world of humans and made everybody fear for their jobs and their futures, 2024 was the year that the narrative changed.
The past 12 months have seen astonishing developments in ... |
| 11.12.2024 | The AI Revolution: Transforming Healthcare and IT for a New Era | Artificial Intelligence (AI) is not just a buzzword; it’s a tidal wave reshaping industries. In healthcare and IT, AI is the engine driving efficiency, precision, and innovation. The transformation is profound, with each sector harnessing A... |
| 11.12.2024 | AI transforming healthcare with better outcomes & efficiency | The healthcare industry is experiencing significant changes driven by advancements in artificial intelligence (AI), which is altering how care is delivered and improving patient outcomes.
The global AI in healthcare market is on a growth pa... |
| 19.11.2024 | Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology | – Integrating Deep Bio’s DeepDx Prostate Algorithm into PathAI’s AISight IMS Platform SEOUL, SOUTH KOREA, November 19, 2024 /EINPresswire.com/ -- Deep Bio, a leader in artificial intelligence for digital pathology, announced a collaboration... |
| 08.11.2024 | Advex AI: Manufacturing AI Vision Company Secures $3.5 Million (Seed) | Advex AI, a company that is addressing the critical data problem in AI Vision for manufacturing, announced their $3.5 million seed funding round led by Construct Capital, with participation from Pear VC, Emerson Collective, and notable ange... |
| 10.09.2024 | Amid Record Growth and Adoption of Judi Clinical Trial Collaboration Platform, AG Mednet Announces New Key Leadership Appointments | BOSTON, Sept. 10, 2024 /PRNewswire/ -- AG Mednet, the pioneering force in clinical trial process management, continues to experience rapid growth and momentum, driven by the widespread adoption of its Judi platform on over 2,000 clinical tr... |
| 29.08.2024 | PathAI’s AISight Dx Receives CE Mark for Primary Diagnosis | What You Should Know:
– PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.
– The certification paves ... |
| 13.08.2024 | PathAI Introduces AI-Based Measurement for MASH Scoring | What You Should Know:
– PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).
– The new product offers advanced AI-based measurement tools to support... |
| 27.07.2024 | Navigating the Future of Healthcare: Innovations and Financial Growth | The healthcare landscape is shifting. New technologies and strategies are emerging, aiming to improve patient care and streamline operations. Two companies at the forefront of this transformation are Navvis and Quest Diagnostics. Their rece... |
| 23.07.2024 | Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 | Second quarter revenues of $2.40 billion, up 2.5% from 2023
Second quarter reported diluted earnings per share ("EPS") of $2.03, down 1.0% from 2023; and adjusted diluted EPS of $2.35, up 2.2% from 2023
Full year 2024 revenues now... |
| 27.05.2024 | Microsoft Build 2024 Unveils Cutting-Edge AI Innovations and Partnerships | The highly anticipated Microsoft Build 2024 event has taken the tech world by storm, showcasing a myriad of groundbreaking AI technologies and forging strategic partnerships to drive innovation. From the unveiling of Copilot+ PCs, the faste... |
| 24.05.2024 | AI-Powered Pathology Technology Company Develops Pan-Cancer Initiatives Across the Drug Development Lifecycle | AI-powered pathology technology company PathAI has partnered with Aster Insights. The new partnership will develop curated multimodal datasets that pair PathAI’s PathExplore artificial intelligence (AI) tumor microenvironment (TME) quantifi... |
| 14.05.2024 | PathAI Unveils AI Foundation Model Built for Disease Detection | What You Should Know:
– PathAI, a leader in the field of AI-powered pathology, has announced the launch of Pathology Universal Transformer (PLUTO), a foundation model specifically designed for the intricacies of pathology, promising to tran... |
| 11.03.2024 | Artificial Intelligence in Healthcare Market Size, Share And Growth Analysis For 2024-2033 | Artificial Intelligence In Healthcare Global Market Report 2024 – Market Size, Trends, And Global Forecast 2023-2032
The Business Research Company's Artificial Intelligence In Healthcare Global Market Report 2024 – Market Size, Trends, And ... |
| 14.02.2024 | Roche Enters into Collaboration Agreement with PathAI | PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD’s companion diagnostics business
Roche announced that it has entered into an agreement with PathAI... |
| 13.02.2024 | PathAI, Roche to Develop AI-Enabled Digital Pathology Algorithms for Companion Diagnostics | What You Should Know:
PathAI, a pioneering AI-powered precision pathology company, has just announced an exclusive collaboration with Roche Tissue Diagnostics (RTD) aimed at advancing AI-enabled interpretation for companion diagnostics.
Thr... |
| 31.01.2024 | PathAI Expands PathExplore Reach to 14 Cancer Types, Fueling Precision Oncology | What You Should Know:
– PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal.
– The expansion doubles the platform’s reach, now covering... |
| 15.06.2023 | PathAI Announces New Executive Appointment to Drive Commercial Growth of Biopharma Partnerships, Lab Capabilities, and Clinical Innovation | PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that Matt Grow has joined as president of biopharma and chief business officer. The role will support PathAI’s expanding biopharma commercial ... |
| 10.03.2023 | PathAI Announces Early Adoption of its Digital Pathology Platform and Algorithms by Leading Anatomic Pathology Laboratories | PathAI, a global leader in AI-powered pathology, announced the launch of AISight, PathAI’s digital pathology platform, and the AIM-PD-L1 NSCLC RUO algorithm, which quantitates the percent of PD-L1 positive tumor and immune cells in non-smal... |
| 17.02.2023 | PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy | PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that Nick Anderson, Ph.D., has joined as Vice President of Regulatory Affairs, while Hisani Madison, Ph.D., MPH, has joined as the Franchise H... |
| 14.11.2022 | Weekly AiThority Roundup: Biggest Machine Learning, Robotic And Automation Updates – November Week 02 | This is your AI Weekly Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and ... |
| 08.11.2022 | PathAI to Present on AI Models Supporting Advances in Oncology Research | PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that the organization’s recent research will be presented at the Society for Immunotherapy of Cancer’s 37th annual meeting (SITC), which will ... |
| 03.11.2022 | PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease | PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, announced that the organization’s recent research will be presented at the upcoming 2022 AASLD 2022 Liver Meeting, which will be held in Washington, D... |
| 14.10.2022 | What is medical artificial intelligence (AI)? | Did you miss a session from MetaBeat 2022? Head over to the on-demand library for all of our featured sessions here.
Table of contents
Risks and rewards
What are the challenges of medical AI?
What are the opportunities for medical AI?
What ... |
| 10.09.2022 | Biden's Commerce secretary spoke on an AI committee while her husband held stocks in AI. It isn't illegal, but it could pose an ethical problem in the future, government watchdog expert says. | Secretary of Commerce Gina Raimondo spoke about advancing AI during a May committee meeting.
Meanwhile, Raimondo's husband exercised up to $150,000 in stock options at his AI company in December 2021.
Advertisement
Department of Commerce Se... |
| 21.04.2022 | 'Digital health' investments surged by 79 per cent in 2021, says Hampleton Partners' Healthtech Report | Mental health and wellness; medical imaging and AI-based diagnostic software; and clinical trials technology proved most attractive to investors
London, UK – 21 April 2022. Hampleton Partners’ latest Healthtech M&A Market Report highlig... |
| 11.11.2021 | PathAI and Novo Nordisk present AI-powered Scoring Showing Significant Reduction of Fibrosis Following Semaglutide Treatment in Patients With NASH | PathAI, a global leader of AI-powered technology applied to pathology, announced new data showing AI-based assessment, including use of PathAI’s AIM-NASH tool, of key histological features of non-alcoholic steatohepatitis (NASH) following s... |
| 22.10.2021 | PathAI Welcomes Two New Executives as it Strengthens its Biopharma Business Leadership Team | PathAI, a leading provider of AI-powered technology, announces that Saumya Pant, Ph.D., joins PathAI as Vice President, Laboratory Strategy and Operations to lead the newly formed PathAI biopharma laboratory business and Jiayi Hao joins as ... |
| 24.06.2021 | PathAI to Present Machine Learning-Based Drug Development Tool For Assessment of Nonalcoholic Steatohepatitis Histopathology at the International Liver Congress 2021 | |
| 04.06.2021 | PathAI and Genentech Present on AI-Powered Pathologic Response Assessment in NSCLC at the American Society of Clinical Oncology Virtual Scientific Program 2021 | |
| 20.05.2021 | PathAI closes $165M Series C | PathAI, a developer of AI-based technology that helps pathologists diagnose and treat diseases like cancer, has raised a $165 million Series C led by D1 Capital and Kaiser Permanente. About a dozen new and returning investors joined the rou... |
| 19.05.2021 | PathAI finds its way to $165M series C for diagnostic and drug development software | If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved in gold.
YOU vs. "UNSOLVABLE" PROBLEMS
Sponsored by Regeneron
Let's s... |
| 18.05.2021 | PathAI Raises $165M to Advance Disease Research and Drug Development | Image: Shutterstock
Despite how far the medical field has come over the decades, diagnostics — especially when it comes to diagnosing cancer — is not an exact science, yet. Doctors can still make mistakes when trying to locate microscopic c... |
| 18.05.2021 | PathAI Announces Completion of $165 Million Financing for Advancing Medicine with AI-powered Pathology | |
| 08.03.2021 | Refraction AI Raises $4.2 Million to Accelerate Reliable, Affordable, Sustainable Last-Mile Robot Delivery for the Masses | With new capital, the company plans to expand both the geographic and industry reach of its last-mile delivery as a service offering.
AUSTIN, Texas and ANN ARBOR, Mich. (PRWEB) March 08, 2021
Refraction AI, the robotics startup and creator ... |
| 29.01.2021 | PathAI Machine Learning Models Reveal Treatment-Induced Changes in the Non-Small Cell Lung Cancer Tumor Microenvironment in Samples from the LCMC3 Study | BOSTON (PRWEB) January 29, 2021
PathAI, a global provider of AI-powered technology applied to pathology research, announced that machine learning models were developed and applied on NSCLC samples from the LCMC3 trial by Genentech, a member... |
| 09.12.2020 | PathAI Present Machine Learning Models that Predict the Homologous Recombination Deficiency Status of Breast Cancer Biopsies at the 2020 SABCS | BOSTON (PRWEB) December 09, 2020
PathAI, a global provider of AI-powered technology applied to pathology research, today announced the result of a proof-of-concept investigation into ML model prediction of HRD directly from H&E-stained ... |
| 30.08.2020 | The Peace Dividends Of The Autonomous Vehicle Wars | The technology advances achieved by autonomous vehicle researchers will proliferate across the ... [+] economy in the years ahead.Getty Images |
| 06.12.2019 | Analysis: November 2019 Health IT M&A Activity, Public Company Performance | – Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of November 2019
We did a doubletake when we noticed all of the HGP health... |
| 11.11.2019 | Pathology Research Tech Company PathAI Closes $75 Million In Funding | PathAI announced that it has closed $75 million in Series B funding with the addition of strategic investments from the Merck Global Health Innovation Fund and Bristol-Myers Squibb
Boston-based PathAI — a leader in AI-powered technology for... |
| 07.11.2019 | ObsEva shares crater after PhIII fail; Allena Pharma unveils positive late-stage data | → Swiss biotech ObsEva SA — focused on treatments to improve women’s reproductive health — shared some dismal news today when it announced that its Phase III clinical trial of nolasiban in women undergoing embryo trans... |
| 06.11.2019 | Merck, BMS chip in to PathAI's series B, bringing total to $75M | Seven months after banking $60 million, PathAI is at it again. Bristol-Myers Squibb and Merck's Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new d... |
| 06.11.2019 | PathAI's $15M from Merck, BMS caps off its $75M Series B | |
| 05.11.2019 | Digital pathology startup PathAI closes $75M Series B round with investments from BMS, Merck | “Merck, BMS and other strategic partners understand that having these best possible insight into the data is incredibly important for driving continued advancements in the rapidly moving field of immuno-oncology, ultimately helping to bring... |
| 04.11.2019 | PathAI Completes $75M in Series B |
AUSTIN, TX, PathAI has secured strategic investments from the Merck Global Health Innovation Fund (Merck GHIF) and Bristol-Myers Squibb.
>> Click here for more funding data on PathAI
>> To export PathAI funding data to PDF a... |
| 04.11.2019 | PathAI Announces Investment from Merck Global Health Innovation Fund and Bristol-Myers Squibb | PathAI, a global leader in artificial intelligence-powered technology for advancing pathology research, announced today that it has secured strategic investments from the Merck Global Health Innovation Fund (Merck GHIF) and Bristol-Myers Sq... |
| 04.11.2019 | PathAI Announces Strategic Investment from Merck Global Health Innovation Fund and Bristol-Myers Squibb | PathAI, a global leader in artificial intelligence-powered technology for advancing pathology research, announced today that it has secured strategic investments from the Merck Global Health Innovation Fund (Merck GHIF) and Bristol-Myers Sq... |
| 04.11.2019 | PathAI Receives Investment from Merck and Bristol-Myers Squibb; Completes $75M Series B | PathAI, a Boston, MA-based provider of artificial intelligence-powered technology for advancing pathology research, secured strategic investments from the Merck Global Health Innovation Fund (Merck GHIF) and Bristol-Myers Squibb.
The compan... |
| 13.09.2019 | Boston gets a new biotech accelerator with the launch of Petri | As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch companies focused on the commercialization of ... |
| 24.07.2019 | PathAI Receives Strategic Investment from LabCorp | PathAI, a Boston, MA-based provider of artificial intelligence-powered technology for use in pathology research, secured an investment from LabCorp (NYSE: LH), a global life sciences company.
The amount of the deal was not disclosed.
The co... |
| 19.07.2019 | Some of the top precision health startups funded in 2019 | The precision medicine space is expected to grow to over $216.75 billion by 2028
Precision health, which is medicine that is tailored to each individual person, using their genes to figure out what treatments will work best for that individ... |
| 02.05.2019 | Job Alert: Boston Startups and Tech Companies Hiring in May | Do you know when to open the door? If you’re considering a career change, look no further than these Inno-approved job openings in and around Boston this May.
Here are just a few of the tech companies and firms that are hiring.
For more opt... |
| 22.04.2019 | PathAI raises $60M for deep learning-based pathology programs | To help power its artificial intelligence-based pathology services, PathAI has raised $60 million in venture capital funding, with plans to accelerate its R&D into new digital tools and medical devices for the diagnosis and classificati... |
| 22.04.2019 | PathAI raises $60M for deep learning-based pathology programs | To help power its artificial intelligence-based pathology services, PathAI has raised $60 million in venture capital funding, with plans to accelerate its R&D into new digital tools and medical devices for the diagnosis and classificati... |
| 19.04.2019 | Boston-Based AI-Powered Pathology Company PathAI Secures $60 Million | PathAI, a Boston-based company that developed artificial intelligence-powered technology for pathology, announced it raised $60 million in Series B funding. This round of funding was led by new investor General Atlantic. General Catalyst al... |
| 18.04.2019 | Top startup news for today, Thursday, April 18, 2019 | Good morning! Below are some of the top tech startup news stories for today, Thursday, April 18.
Samsung’s $2,000 folding phone is breaking for some users after two days of use. Last week, we wrote about Samsung when the company introduced... |
| 18.04.2019 | PathAI's $60M Series B will fuel continued growth of its digital pathology platform | |
| 18.04.2019 | PathAI raises $60 million Series B funding to improve cancer diagnosis using artificial intelligence | PathAI, a healthtech startup with mission to improve cancer diagnosis using artificial intelligence, has has raised $60 million in Series B funding to enhance offerings to existing partners, drive continuous improvement of its flagship path... |
| 17.04.2019 | Boston-based AI pathology startup rakes in $60M Series B round | Simply put, PathAI has technology that helps pathologists make fast and accurate diagnoses for patients. Additionally, it’s creating solutions to pinpoint patients that would benefit from certain therapies.
“Our goal has been clear since da... |
